Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Morganna's Alchemy is a specialized cosmeceutical company that develops high-performance skincare solutions using advanced green chemistry and biotechnological actives. Founded by chemist Maya Hyppolite-Macias, the company focuses on addressing complex skin concerns such as aging, hyperpigmentation, and acne through the use of plant stem cells and synthetic peptides. Their product formulations are designed to bridge the gap between traditional cosmetics and clinical dermatology, utilizing eco-certified ingredients to ensure sustainability. The brand is well-regarded for its innovative use of exotic plant extracts and its commitment to cruelty-free, science-based beauty. Morganna's Alchemy operates primarily through direct-to-consumer channels and professional aesthetic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Morganna's Alchemy.